Basic & Clinical Medicine ›› 2016, Vol. 36 ›› Issue (8): 1068-1073.
Previous Articles Next Articles
Received:2015-06-12
Revised:2015-11-12
Online:2016-08-05
Published:2016-07-13
Supported by:CLC Number:
| [1] | LU Wei, WANG Yanmin, LIU Bingchen, TAO Xin, WANG Shipeng, CAO Qiuye. Berberine enhances the chemotherapy sensitivity of prostate cancer cell line 22RV1 to docetaxel [J]. Basic & Clinical Medicine, 2026, 46(1): 39-45. |
| [2] | ZHANG Yufeng, ZHANG Xinna, ZHOU Yanjiao. PHLPP2 variation is associated with prognosis as well as ferroptosis in patients of advanced lung adenocarcinoma harboring EGFR+TP53 co-mutations [J]. Basic & Clinical Medicine, 2026, 46(1): 103-108. |
| [3] | LI Binfeng, LYU Fayou, YI Huijun, LYU Lyu. Advances in the mechanism of action of the ring finger proteins family in breast cancer [J]. Basic & Clinical Medicine, 2026, 46(1): 124-128. |
| [4] | WANG Junxia, XIE Zaidong, PAN Chunlei, WU Feng, LIU Dingsheng, ZHU Jianrong, ZHAO Chunhua. Comparison of biological characteristics of natural killer cells from different sources [J]. Basic & Clinical Medicine, 2025, 45(12): 1668-1674. |
| [5] | ZHANG Yanchi, SHI Junqi, ZHANG Yijun, DUAN Jiawen, LIU Jinyu, ZHANG Liyan, LIANG Wanping. Advances in synergistic therapies targeting metabolic mechanisms and the immune microenvironment in breast cancer [J]. Basic & Clinical Medicine, 2025, 45(12): 1662-1667. |
| [6] | ZHANG Hui, GAN Shibao, LI Hui, ZHOU Jiaxun, ZHAO Mengqi. Silencing KRT17 inhibits proliferation of human esophageal squamous cell line KYSE-150 [J]. Basic & Clinical Medicine, 2025, 45(12): 1548-1556. |
| [7] | LI Wenhui, REN Honggang, GUO Jian, SONG Yang, FENG Fuqiang. miR-141-3p down-regulating lysophosphatidic acid receptor3 inhibits proliferation, migration and epithelial-mesenchymal transition of brain glioma cells [J]. Basic & Clinical Medicine, 2025, 45(12): 1580-1587. |
| [8] | TAN Shufen, WANG Qian, ZHANG Lei, ZHANG Yi, LI Shuqing. Application of PDCA cycle and TBL embedded teaching method in clinical training program of gynecologic oncology [J]. Basic & Clinical Medicine, 2025, 45(11): 1532-1535. |
| [9] | SHI Dongxue, WANG Ruihan, LYU Beibei, LIN Xiaoyan. Research progress on the role of butyrylation modification in malignant tumors [J]. Basic & Clinical Medicine, 2025, 45(11): 1496-1500. |
| [10] | WANG Juzheng, LU Jiayu, WANG Qingshi, LIU Wen, BAO Bo, LI Yiming, LU Qiang. Upregulation of miR-1287-5p promotes paclitaxel resistance in human esophageal cancer cell line KYSE30 [J]. Basic & Clinical Medicine, 2025, 45(11): 1473-1479. |
| [11] | HAN Wei, PAN Wei, ZHANG Man, GAO Xiangyu, KANG Xinkai, ZHU Zhibo, LIU Ruiting. Scoparone inhibits proliferation and invasion of colon cancer cell line HCT116 [J]. Basic & Clinical Medicine, 2025, 45(11): 1429-1437. |
| [12] | LI Wenhua, WANG Runlin, KANG Qianpeng, HUANG Mei, GUO Zhengguang, ZHANG Chunlin, HUANG Yongsheng. p97 inhibitor EerⅠ induces apoptosis and ferroptosis of gastric cancer cell line AGS [J]. Basic & Clinical Medicine, 2025, 45(11): 1401-1408. |
| [13] | LIU Fengshuo, GUAN Mei. Treatment of antibody-drug conjugates in elderly patients [J]. Basic & Clinical Medicine, 2025, 45(10): 1270-1276. |
| [14] | GE Yuping, HUA Yuwei, WANG Lina, HOU Xiufeng, SONG Hua, GUO Xinying, ZHANG Yuan, WANG Yanan, GUAN Mei. Impact of a modified CARG model guiding anticancer drug dose adjustments on adverse events in elderly cancer patients [J]. Basic & Clinical Medicine, 2025, 45(10): 1277-1283. |
| [15] | ZENG Chengyu, QIU Wei, SONG Hua, GUO Xinying, YING Hongyan. Challenges and management strategies of anti-tumor treatment for renal insufficiency in elderly patients with malignant tumors [J]. Basic & Clinical Medicine, 2025, 45(10): 1262-1269. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||